Indefinite Delivery Contract 75D30122D15431

Award Date 9/20/22
Last Date to Order 9/19/27
Federal Agency
CDC Pittsburgh
Awardee
Acumen LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has awarded an Indefinite Delivery Contract (IDC) valued at up to $75 million to Acumen LLC, doing business as Medric, to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3). The contract will provide CBER with access to large-scale, longitudinal healthcare data covering tens of millions of patients, including both administrative claims...
The Centers for Disease Control and Prevention awarded an indefinite-delivery/indefinite-quantity multiple award contract under the Vaccine Safety Datalink master contract with a potential value of $149 million. Marshfield Clinic was awarded a delivery order for $3.75 million to provide vaccine safety data link services on a cost-no-fee basis from September 2022 through September 2027 in Marshfield, Wisconsin. The Vaccine Safety Datalink aims to procure ongoing vaccine safety monitoring and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a ceiling value of $4,116,159,200 and a period of performance from April 1, 2025 to March 30, 2026. The IDC is for the procurement of standard commercial pediatric vaccines to support the Vaccines for Children (VFC) program, which provides immunizations...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, valued at a ceiling of $66,688,290, is for the procurement of adult vaccines under the VACCINES major program code. The contract has a period of performance from July 1, 2025 to June 30, 2026. As an established federal contractor, Merck holds several significant IDVs with the CDC,...
The federal contract IDV award is for the Vaccine Safety Datalink (VSD) program, a collaborative project between the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and several healthcare organizations. The prime contractor is Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. This is a multiple award Indefinite Delivery Contract (IDC) with a $149 million ceiling value and...
The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery/indefinite-quantity contract to Ochin, Inc. to provide Vaccine Safety Datalink services. With a potential value of $149 million and a period of performance through September 2027, this master contract will support the CDC's collaborative project with nine managed care organizations to monitor vaccine safety and conduct clinical research. Two delivery orders have been issued against this master contract to...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the U.S. federal government. The contract has a total ceiling value of $3,942,689,200 and a period of performance from April 1, 2023 through March 31, 2024. The purpose of this IDC is to establish contracts for the purchase of a minimum of 100 doses up to maximum quantities...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), to Merck Sharp & Dohme LLC, doing business as Merck, to provide a variety of pediatric vaccines in support of the CDC's Immunization Awardees program and Vaccines for Children program. The contract has a ceiling value of $4,079,096,100 and a period of performance from April 1, 2024 through March 31, 2025. The...
The Centers for Disease Control and Prevention awarded an indefinite-delivery indefinite-quantity multiple award contract under the Vaccine Safety Datalink program. With a potential value of one hundred forty-nine million U.S. dollars and a period of performance through February 2027, this contract provides vaccine safety data linking services. Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, operating as Kaiser Permanente, received a five million eight hundred...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Acumen LLC, doing business as Medric, for the Vaccine Safety Datalink (VSD) program. The VSD is a collaborative project between the CDC and several healthcare organizations to monitor the safety of vaccines.

Under this $149 million multiple-award IDC, Medric will provide a range of data analytics, research, and program support services to the CDC to support the VSD. This includes a $5.2 million cost-plus-fixed-fee delivery order for ongoing VSD activities. Medric, a for-profit limited liability company, specializes in leveraging data resources to inform federal, state, and local health policy and programs. The contract has no set-aside designation, and the period of performance runs through September 2027, with work to be performed primarily in Burlingame, California.

Generated 9/7/24, 10:23 AM